Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01878643 · ClinicalTrials.gov registry record · Early Phase 1
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
A Early Phase 1 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 47
- Enrollment target
NCT01878643 is a Early Phase 1 study that has completed, run by Stony Brook University. The registered enrollment target is 47 participants.
The verdict
NCT01878643, a Early Phase 1 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study was : * to determine the effect of inhaled antibiotics on airway bacteria in ventilated patients * to determine the effect of inhaled antibiotics on respiratory infection
Interventions
- DRUG Placebo
- DRUG vancomycin or gentamicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2001-12 |
| Est. Completion | 2002-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01878643
The ClinicalTrials.gov registry entry for NCT01878643 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01878643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01878643 about?
NCT01878643 is a clinical study titled "Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit". The purpose of this study was : * to determine the effect of inhaled antibiotics on airway bacteria in ventilated patients * to determine the effect of inhaled antibiotics on respiratory infection
What is the current status of trial NCT01878643?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 47 participants. The study started on 2001-12. Estimated completion is 2002-12.
What interventions are being tested in trial NCT01878643?
The interventions under investigation include: Placebo (DRUG), vancomycin or gentamicin (DRUG).
Who is sponsoring clinical trial NCT01878643?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.